MX69

CAS No. 1005264-47-0

MX69( MX 69 | MX-69 )

Catalog No. M10044 CAS No. 1005264-47-0

A novel specific inhibitor of MDM2 inhibitor with Kd of 2.75 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 56 In Stock
2MG 33 In Stock
5MG 53 In Stock
10MG 93 In Stock
25MG 170 In Stock
50MG 269 In Stock
100MG 423 In Stock
200MG 609 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MX69
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel specific inhibitor of MDM2 inhibitor with Kd of 2.75 uM.
  • Description
    A novel specific inhibitor of MDM2 inhibitor with Kd of 2.75 uM; induces ubiquitination of endogenous MDM2, results in activation of p53 and inhibition of XIAP, and induces cell apoptosis and death in cancer cells; shows significant apoptotic and anti-proliferative effects on MDM2-expressing cancer cells both in vitro and in vivo, with minimal inhibitory effect on normal human hematopoiesis.
  • In Vitro
    MX69 blocks the MDM2 protein-XIAP RNA interaction, leading to MDM2 degradation. MX69 shows minimal inhibitory effect on normal human hematopoiesis in vitro and is very well tolerated in animal models. MX69-induced MDM2 down regulation results not only in inhibition of XIAP expression, but also in activation of p53, which contributes to cancer cell apoptosis in vitro.
  • In Vivo
    MX69-induced MDM2 downregulation results in activation of p53 which contributes to inhibition of cancer cell proliferation in vivo.
  • Synonyms
    MX 69 | MX-69
  • Pathway
    Apoptosis
  • Target
    MDM2-p53
  • Recptor
    Mdm2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1005264-47-0
  • Formula Weight
    474.57134
  • Molecular Formula
    C27H26N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 30 mg/mL
  • SMILES
    O=S(C1=CC2=C(NC(C3=CC=C(C(O)=O)C=C3)C4C2C=CC4)C=C1)(NC5=C(C)C(C)=CC=C5)=O
  • Chemical Name
    4-{8-[(3,4-Dimethylphenyl)sulfamoyl]-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl}benzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gu L, et al. Cancer Cell. 2016 Oct 10;30(4):623-636.
molnova catalog
related products
  • Relugolix

    Relugolix is an orally available, non-peptide gonadotropin-releasing hormone (GnRH or luteinizing hormone-releasing hormone (LHRH)) antagonist, with potential antineoplastic activity.

  • RETRA

    RETRA is a small molecule mutant p53 reactivator that activates a set of p53-regulated genes and specifically suppresses mutant p53-bearing tumor cells in vitro and in mouse xenograft.

  • MB710

    MB710 is a small-molecule p53 mutant Y220C stabilizer, binds tightly to the Y220C pocket and stabilizes p53-Y220C in vitro.